Apical dose versus volume dose of Ruthenium-106 brachytherapy for uveal melanoma
CONCLUSION: D99% and apex dose are affected by tumour and treatment characteristics in different ways, highlighting the complexity of radiation delivery to uveal tumours.PMID:38582499 | DOI:10.1016/j.jcjo.2024.03.007
Source: Canadian Journal of Ophthalmology - Category: Opthalmology Authors: Jeremy P M Flanagan Lotte S Fog Melvin A Astrahan Lachie J Talbot Daniel McKay Claire Phillips John D McKenzie Roderick O'Day Source Type: research
More News: Brachytherapy | Canada Health | Eye Cancers | Melanoma | Opthalmology | Skin Cancer | Uveal Melanoma